UPDATE 1-Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
LONDON, Jan 7 (Reuters) - Treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care,
View the full story here: https://www.msn.com/en-us/health/medical/update-1-roche-sanofi-arthritis-drugs-reduce-death-rates-among-sickest-covid-19-patients/ar-BB1cyKH3